FDA Approves Endari (L-glutamine oral powder) for Sickle Cell Disease

July 7, 2017 -- The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder. " Endari is the...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news